This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit

Case Simulation: A Multidisciplinary Approach to Navigating the Complexity of PAH Diagnosis and Treatment


Patient Case Simulations

Time to Complete

1 hour


September 15, 2019


September 15, 2020
Add to Queue

Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
1.00 / CE for Nurse Practitioners (0.10 pharmacology credit)

Accredited Provider

CME/CE Credit provided by Global Education Group

Activity is jointly-provided by Global Education Group and Tarsus

Commercial Supporter

This educational activity is supported by an educational grant from Actelion Pharmaceuticals US, Inc.

Program Description

Due to the changing epidemiology, clinicians from various disciplines may encounter patients with pulmonary arterial hypertension (PAH), who may present with a different range of non-specific symptoms , comorbidities and risk factors. As a result, clinicians need to be aware of PAH in order to diagnose patients or adequately refer them to specialty care. A multidisciplinary approach to care is recommended to optimize patient outcomes, and clinicians need to be aware of risk factors, guideline recommendations for multidimensional assessment and individualized treatment, and current treatment options for PAH.

This two-part educational activity includes a didactic lecture and an interactive, case-based simulation technology that will provide learners with the opportunity to enhance clinical decision-making skills about the diagnosis and management of PAH.

Intended Audience

US-based healthcare professionals, including primary care clinicians (PCPs), nurse practitioners (NPs), and other allied health professionals.

Educational Objectives

Upon completion of the activity, participants should be better able to:

  • Identify patients with PAH based on symptoms, risk factors, and screening strategies outlined in updated evidence-based guidelines
  • Explain the latest guidelines for the management of PAH
  • Review the efficacy and safety of current treatment options for PAH, including combination therapies, according to the recent evidence-base and treatment advances
  • Develop individualized treatment regimens based on the multidisciplinary approach to care for PAH that takes into account treatment goals, long-term assessment, and comorbidities in order to improve patient outcomes

Conflict Of Interest Disclosure Policy

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.


Sonja Bartolome, MD, FCCP
Associate Professor
Pulmonary and Critical Care Medicine
UT Southwestern Medical Center
Dallas, TX

Dr. Bartolome discloses the following:
Consultant/Independent Contractor: Bayer, Actelion
Grand/Research Report: Reata, PhaseBio, LungRx, United Therapeutics, Bayer

Accredited Provider Disclosure

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Kristin Delisi, NP; Lindsay Borvansky; Andrea Funk; Amanda Turner; Shpetim Karandrea, PhD; Karin McAdams all have nothing to disclose.




AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and CMHC. Global is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Global Education Group designates this virtual activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.




CE for Nurse Practitioners

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through joint providership of Global Education Group and CMHC. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121.

Designation Statement

This activity is approved for 1.00 contact hour(s) which includes 0.10 hour(s) of pharmacology.

Activity ID #2868E.

This activity was planned in accordance with AANP CE Standards and Policies.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and CMHC do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.

For information about the accreditation of this program, please contact Global at 303-395-1782 or

Privacy Policy


Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue